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SummAry – vascular endothelial dysfunction is a basic etiologic factor for the development 
of late clinical complications in patients with diabetes mellitus type 1, such as diabetic retinopathy, 
diabetic nephropathy (which is characterized at the very beginning by microalbuminuria), and left 
ventricular cardiac dysfunction. The aims of this study were to determine the prevalence of asymp-
tomatic left ventricular systolic dysfunction in patients with diabetes mellitus type 1 and with or wi-
thout diabetic retinopathy and microalbuminuria, and to correlate the duration of diabetes with the 
dynamics of diabetic retinopathy, microalbuminuria and asymptomatic left ventricular dysfunction 
development in these patients. One-hundred and twenty selected patients with diabetes mellitus 
type 1 were examined by ophthalmologist and cardiologist. All patients underwent ergometric te-
sting and two-dimensional (2-d) echocardiography with pulsed doppler. Patients were divided into 
three groups according to their fundus findings and microalbuminuria: (1) patients without diabetic 
retinopathy and without microalbuminuria (n=40); (2) patients with diabetic retinopathy without 
microalbuminuria (n=40); and (3) patients with diabetic retinopathy and microalbuminuria (n=40). 
All three groups of patients with diabetes mellitus type 1 (with low cardiovascular risk, regulated 
blood sugar, and without diabetic neuropathy) had echocardiographic values in the normal range. 
we found no statistically significant correlation between the duration of diabetes mellitus type 1 
and echocardiographic values.
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Introduction
diabetes mellitus type 1 (dm1) is a complex, 
polygenetic, chronic, autoimmune disease character-
ized by selective destruction of ß-cells in pancreatic 
islets1,2. diabetes mellitus (dm) causes generalized 
microangiopathy in late stages and is the most im-
portant cause of cardiovascular diseases3. endothelial 
dysfunction is the most important etiologic factor for 
microangiopathy, and affects mostly small vessels in 
the retina, renal glomeruli, peripheral nerves, and all 
cardiovascular system components including small 
blood vessels, great arteries and the heart4-6.
microangiopathic heart changes are the same as 
in other organs, so these patients often, in the be-
ginning, have asymptomatic dysfunction of the left 
ventricle7,8. regarding diffuse microangiopathy in pa-
tients with dm, we can suppose that patients with 
diabetic retinopathy (which appears frequently and 
before microalbuminuria), as a sign of systemic mi-
croangiopathy, also have myocardial microangiopa-
thy, which may cause systolic dysfunction of the left 
ventricle. Systolic heart dysfunction implies more dif-
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ficult left ventricular discharge, which manifests with 
lower ejection fraction (ef)9.
The aim of this study was to determine left ven-
tricular systolic dysfunction in patients with dm1 
and clinically (un)evident diabetic retinopathy (dr) 
with or without associated microalbuminuria, and to 
evaluate correlation between the duration of dm1 
and the first appearance of dr, microalbuminuria, 
and asymptomatic left ventricular dysfunction.
Material and Methods
Statistics
data analysis was performed with the help of the 
SPSS17.0 statistical package. distribution of categor-
ical and metric variables was performed and the dis-
tribution of metric variables tested (normal or gauss-
ian, Kolmogorov Smirnov test). if the distribution of 
metric variables proved normal, parametric methods 
(AnOvA and duncan test; AnCOvA) were used to 
test differences among the three test groups. if the dis-
tribution of metric variables was not normal, nonpara-
metric methods were used (Kruskal-wallis analysis of 
variance and mann-whitney test). we used χ2-test 
to determine the association of categorical variables 
with the three groups of patients. Logistic regression 
analysis was used for each variable (cardiac function) 
separately to assess correlation of the test variables 
with dr and dr together with microalbuminuria. 
results were interpreted at the level of p<0.05.
Methods
we examined 154 patients with dm1. inclusion 
criteria were the onset of the disease at the age be-
tween 12 and 30 years; duration of the disease ≥5 
years; regulation of glycemia expressed as hbA1c value 
<9%; systolic blood pressure ≤130 mm hg, diastolic 
blood pressure ≤80 mm hg; absence of diabetic auto-
nomic neuropathy, absence of complete opacification 
of the optic media and of other vascular ophthalmic 
diseases; absence of other heart, kidney and hemato-
logic anomalies and diseases.
we excluded 34 patients because of hypertension 
(n=14), presence of autonomic diabetic neuropathy 
(n=7), poor metabolic control of the disease (n=6), 
positive coronary reserve test (n=4), lens opacification 
(n=2), and urinary tract infection (n=1). All patients 
voluntarily participated in the study (n=120) and 
signed the informed consent form.
All patients underwent direct and indirect oph-
thalmoscopy in mydriasis, stereo fundus photography, 
and fluorescein angiography. fundus photography 
and fluorescein angiography were done with a fundus 
camera (Zeiss ff 450 plus ir). Apart from urinary 
sediment analysis, turbidimetric evaluation of mi-
croalbuminuria in 24-h urine was also done twice in 
all patients, 15 days apart, using the muLtiGent 
immunoassay on the ArChiteCt cSyStemS 
(Abbott diagnostics). if the mean value of two mea-
sures of microalbuminuria was ≥30 mg/24 h, it was 
considered as positive finding. Patients with dm1 
(n=120) were divided into three groups according to 
funduscopy and microalbuminuria findings: group 1, 
patients without dr and without microalbuminuria 
(n=40); group 2, patients with dr without microal-
buminuria (n=40); and group 3, patients with dr and 
microalbuminuria (n=40).
Ophthalmologist evaluated the autonomic nerve 
system by measuring pupil cycle time (PCt)10. The 
mean PCt value was obtained by calculating it from 
values measured on each eye. we considered the 
time to 954 milliseconds (msec) and the difference 
between the two eyes of 70 msec as reference val-
ues11-13. in order to exclude the presence of coronary 
disease or to evaluate its severity, coronary reserve was 
tested by cardiologist (bruce’s protocol) using ergo-
metric testing (marquette electronics inc., CASe 
12, uSA). echocardiography was performed by the 
same cardiologist using standardized two-dimen-
sional (2-d) technique on the ultrasound machine 
vivid 3-s/w version 1.2 e, with 1.7 mhz probe. 
we measured left ventricular diameter at the end of 
diastole (Lvidd); left ventricular diameter at the end 
of systole (Lvids); diastolic septal thickness (ivSd); 
left ventricular posterior wall thickness in diastole 
(LvPwd); and left atrial diameter (LA) at the level of 
aortal valve. All values were expressed in centimeters 
(cm). from Lvidd and Lvids values, we calculated 
systolic function of the left ventricle expressed as ef. 
ef of the left ventricle (ratio between stroke volume 
and end diastolic volume) was expressed as percent-
age (%) and calculated according to the formula: ef 
= (Lvidd3 - Lvids3) : Lvidd3 x 100. The ef value 
>50% was considered normal.
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Results
The study included 120 patients with dm1, 64 
(53.3%) men and 56 (47.7%) women.
Out of 120 study patients, 40 had dm1 without 


























Table 1. Number of patients with diabetic retinopathy according to groups



























dm1 = diabetes mellitus type 1; †Kruskal-wallis test (post hoc: mann-whitney test) 



















(cm) 0.916±0.13 0.873±0.13 0.944±0.11 0.93±0.14 0.883*
LvPwdd 
(cm) 0.96±0.12 0.934±0.12 0.99±0.12 0.96±0.13 0.379*
LA
(cm) 3.18±0.43 3.05±0.42 3.22±0.41 3.26±0.44 0.635*
ef (%) 71.7±6.60 73.8±5.80 70.3±5.90 70.2±7.60 0.264*
Lvidd = left ventricular diameter at the end of diastole; Lvids = left ventricular diameter at the end of systole; ivSd = 
diastolic septal thickness; LvPwdd = left ventricular posterior wall thickness in diastole; LA = left atrial diameter; ef = 
ejection fraction; *AnCOvA (covariables: age, duration of disease; post hoc: fisher LSd test); †Kruskal-wallis test (post hoc: 
mann-whitney test) 
Table 3. Descriptive values (X̄̄̄ ±SD) or medians (min-max) of echocardiographic variables in all 
groups
had dr along with dm1 (group 2); and 40 patients 
had dm1, dr, and microalbuminuria (group 3) (ta-
ble 1).
The mean age (median) of all patients (n=120) was 
33 years. The lowest age median was recorded in group 
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1. The age of group 2 (Z=5.4; p<0.001) and group 3 
(Z=5.2; p<0.001) patients was significantly higher 
than in group 1. The median age of group 2 and group 
3 patients was twofold that in group 1 (table 2).
The mean (median) duration of dm1 was 11 years 
(lower quartile: 7 years, upper quartile: 18.5 years). The 
duration of the disease in all patients was ≥5 years. The 
duration of dm1 was significantly higher in group 2 
(Z=5.7; p<0.001) and group 3 (Z=5.8; p<0.001) than 
in group 1. in groups 2 and 3, the median of dm1 
duration was twofold that in group 1.
table 3 shows echocardiographic measures. in 
groups 2 and 3, echocardiographic values differed sig-
nificantly from those recorded in group 1, but all were 
within the reference values. Therefore, we aimed to 
determine the relationship between the median of ef 
and dr, microalbuminuria, and duration of dm1. 
ef values were classified into two categories: ≤median 
and >median. 
we performed χ2-test in order to determine ef 
distribution according to dm1 duration (≤11 years 
and >11 years) and groups. This was followed by uni-
variate logistic regression. The χ2-test and univariate 
logistic regression according to groups as predictor 
provide answer to the ef correlation with diabetic 
retinopathy and microalbuminuria.
multivariate ‘forward stepwise (wALd)’ analysis 
was performed to determine the relation of ef with 
the duration of dm1 (≤11 years and >11 years) and 
age (≤33 years and >33 years) as predictors.
Left ventricular ef (expressed in %) was not sig-
nificantly correlated with the group (dr and mi-
croalbuminuria) (χ2=4.49; p=0.106), but group 1 was 
significantly different from groups 2 and 3 together 
(χ2=4.3; p=0.038) (table 4). neither univariate logistic 
regression (p=0.065) nor multivariate logistic regres-
sion (predictors: duration of dm1 and age) yielded 
significant correlation of ef ≤71% with the duration 
of dm1 (p=0.366) (table 5).
echocardiographic values, age and duration of the 
disease did not significantly differ between group 2 
(dm1 and dr) and group 3 (dm1, dr and microal-
buminuria) patients. Since patients in these groups 
were older than group 1 patients (dm1 without com-
plications), we matched the group 2 and 3 patients 
with group 1 patients according to age and duration 
of dm1. we obtained two groups of 26 patients each, 
matched for age and dm1 duration. The mean (me-
dian) age in group 1 was 22 years (min-max: 17-45 
years), and in the other group of patients it was 21 
Table 4. Distribution of patients and odds ratio (univariate logistic regression) according 
to groups and duration of diabetes mellitus type 1 (DM1) considering median values of 
ejection fraction (EF) ≤71
ef (%)
Predictor ≤71 >71 p† Odds ratio (95% Ci) p‡








dm1 = diabetes mellitus type 1; ef = ejection fraction; *values reported as basal values; †χ2-test; ‡logistic 
regression
Table 5. Odds ratio (multivariate logistic regression) for 
incidence of ejection fraction ≤71% according to duration 
of diabetes mellitus type 1 (DM1) and age
Predictor Odds ratio 95% Ci p
duration of dm1 
(years) <11* 1.6 0.57-4.5 0.366
>11
Age (years) <33* 1.3 0.48-3.8 0.576
>33
dm1 = diabetes mellitus type 1; *values reported as basal values
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years (min-max: 18-49 years) (p=0.978). echocardio-
graphic results in groups 1, 2 and 3, matched accord-
ing to age and dm1 duration, did not show any sig-
nificant difference (table 6).
Discussion
in patients with dm1, tests offer better possibili-
ties of determining the relation between microangio-
pathic complications than in patients with diabetes 
mellitus type 2 because dm1 develops in younger 
patients with less adjunctive variables associated with 
metabolic syndrome and senile atherosclerotic fac-
tors.
The results of our study showed that the mean 
echocardiographic values were within the nor-
mal range in all three groups of patients with dm1 
(n=120) (group 1 without microangiopathic compli-
cations, group 2 with dr, and group 3 with dr and 
microalbuminuria). data analysis showed significant 
difference in echocardiographic variables in patients 
without complications (group 1) as compared with ei-
ther patients with dr or those with dr and microal-
buminuria (groups 2 and 3). There was no significant 
difference between the patients with dm1 and dr 
and those with dm1, dr and microalbuminuria. Left 
ventricular systolic dysfunction values were within the 
normal range in all patients. borow et al. did not find 
any left ventricular systolic or diastolic dysfunction in 
patients with dm114. 
Some authors found significant correlation be-
tween left ventricular systolic dysfunction in patients 
with dm1 when compared with normal popula-
tion15-17. Some other authors found normal left ven-
tricular systolic function and their patients showed 
pathologic values only on physical exercise18. Other 
authors report on normal echocardiographic values of 
left ventricular systolic function in patients with dm1 
even during physical exercise19.
most authors describe normal left ventricular sys-
tolic function in dm1 patients free from microangio-
pathic complications and with low cardiovascular risk 
(normotensive patients without cardiac autonomic 
neuropathy, dyslipidemia, coagulation dysfunction, 
and proteinuria), and with regulated glycemia20-24.
Our results showed that there was no significant 
correlation between dr and ef <71%, and between 
dr and microalbuminuria on the one hand and ef 
<71% on the other. it was also confirmed that there 
was no correlation between ef <71% and duration of 
the disease. raev also examined the relation between 
ef and duration of dm1 and reports a rare occur-
rence of systolic dysfunction until the age of 1823.
rajan and Gokhale report normal ef (mean value 
73%) in the group of patients with dm1 and mi-
croangiopathic complications21, while Konduracka et 
al. report abnormal systolic function in 185 examined 
patients with dm1 and mean duration of the disease 
of 22.8 years24,25. On the contrary, raev reports dete-
rioration of systolic function in 39% of patients with 
dm1 and microangiopathic complications (retinopa-
thy, nephropathy and autonomic neuropathy)26. Some 
authors think that hypertension and cardiac autonom-
ic neuropathy (which is present in more than 40% of 
patients) have great influence on systolic dysfunction 
development, so with this perspective we can observe 
the incidence of systolic dysfunction in the previously 
mentioned study27-30.
in an attempt to correct our data, we matched pa-
tients according to age and duration of dm1, but we 
did not obtain any significant difference among the 
matched groups in any of the echocardiographic vari-
ables or ef.
The most important reasons for different results 
found in other studies may be different inclusion and 
Group 1
(n=26)
Groups 2 and 3
(n=26) p





ivSd (cm) 0.88±0.13 0.89±0.10 0.633*
LvPwdd (cm) 0.94±0.13 0.95±0.10 0.715*
LA (cm) 3.18±0.43 3.13±0.40 0.374*
ef (%) 73±6.0 71±6.4 0.370*
Lvidd = left ventricular diameter at the end of diastole; Lvids = 
left ventricular diameter at the end of systole; ivSd = diastolic septal 
thickness; LvPwdd = left ventricular posterior wall thickness in 
diastole; LA = left atrial diameter; ef = ejection fraction; *t-test; 
†mann-whitney test
Table 6. Descriptive values of echocardiographic variables 
(X̄̄̄ ±SD) or median (min-max) in group 1 patients, and 
in groups 2 and 3 patients, adjusted for duration of diabe-
tes type 1 and age
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exclusion criteria (especially hypertension, neuropa-
thy, and poor blood glucose regulation), and differ-
ent diagnostic methods employed to reveal complica-
tions31.
based on the data gathered on 120 patients with 
dm1, we have drawn the following conclusions:
1. mean values of all echocardiographic variables ex-
amined in this study were within the normal range 
in each of the three groups of examined patients 
with dm1 (with low cardiovascular risk, and 
without diabetic neuropathy).
2. There were significant differences in echocardio-
graphic variables in the group of patients without 
complications (group 1) when compared with the 
group of patients with dr and microalbuminuria 
together (groups 2 and 3).
3. There was no significant difference in echocardio-
graphic variables between the group of patients 
with dm1 and dr and the group of patients with 
dm1, dr and microalbuminuria.
4. There was significant correlation between the du-
ration of dm1, the presence of dr and microal-
buminuria.
5. Systolic function, expressed as left ventricular ef, 
was normal in all patients.
6. There was no significant correlation between dr 
and ef <71%, or between dr, microalbuminuria 
and ef <71%.
7. There was no correlation between ef <71% and 
duration of the disease.
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Sažetak
SiStOLiČKA funKCiJA LiJeve KLiJetKe u OdAbrAnih bOLeSniKA SA ŠećernOm bOLeSti 
tiP 1 S diJAbetiČnOm retinOPAtiJOm i miKrOALbuminuriJOm iLi beZ nJih
K. Bućan, L. Bojić, D. Fabijanić, D. Galetović, V. Čapkun, D. Karlica Utrobičić i I. Bućan
endotelno-vaskularna disfunkcija je temeljni čimbenik u etiologiji razvoja kasnih kliničkih komplikacija u bolesnika 
sa šećernom bolesti tip 1(Šbt1) uključujući dijabetičnu retinopatiju, dijabetičnu nefropatiju (u samom početku obilježenu 
mikroalbuminurijom) i disfunkciju lijeve srčane klijetke. Ciljevi rada bili su odrediti asimptomatsku sistoličku disfunkciju 
lijeve srčane klijetke u bolesnika sa Šbt1 i klinički (ne)evidentnom dijabetičnom retinopatijom i s mikroalbuminurijom 
ili bez nje, te utvrditi povezanost trajanja Šbt1 s pojavom dijabetične retinopatije, mikroalbuminurije i asimptomatske 
sistoličke disfunkcije lijeve srčane klijetke. ispitano je 120 odabranih bolesnika sa Šbt1 (normotenzivni, bez dijabetične 
neuropatije), koji su s obzirom na nalaz fundoskopije (oftalmoskopski, fundus fotografija i fluoresceinska angiografija) i mi-
kroalbuminurije (turbidimetrijskom metodom) svrstani u tri skupine: 1) bolesnici bez dijabetične retinopatije i bez mikro-
albuminurije (n=40); 2) bolesnici s dijabetičnom retinopatijom bez mikroalbuminurije (n=40); 3) bolesnici s dijabetičnom 
retinopatijom i mikroalbuminurijom (n=40). Kod svih bolesnika izvršeno je ergometrijsko testiranje i ehokardiografsko 
ispitivanje dvodimenzijskom (2-d) i pulsnom doppler-ehokardiografskom tehnikom. Kod sve tri skupine bolesnika sa 
Šbt1 (niskog profila kardiovaskularnog rizika, uredne reguliranosti i bez dijabetične neuropatije) srednje vrijednosti 
ehokardiografskih varijabla bile su unutar referentnih vrijednosti. nismo utvrdili statistički značajnu povezanost između 
trajanja Šbt1 i ispitivanih ehokardiografskih varijabla.
Ključne riječi: Šećerna bolest tip 1; Retinopatija; Albuminurija; Srčana klijetka, lijeva, funkcija
